BIO-TECHNE CORP's ticker is TECH and the CUSIP is 09073M104. A total of 514 filers reported holding BIO-TECHNE CORP in Q2 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
About BIO-TECHNE CORP
Bio-Techne Corp is a leading provider of innovative life science research tools and diagnostic solutions. The company is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. Bio-Techne's products and services are used by researchers and clinicians in a wide range of fields, including cancer research, stem cell research, and immunology.
Bio-Techne's success is due in large part to its commitment to innovation and customer service. The company invests heavily in research and development, and has a team of over 1,000 scientists working to develop new products and technologies. Bio-Techne also has a strong focus on customer service, with a dedicated team of technical support specialists available to assist customers with any questions or issues they may have.
In addition to its research tools and diagnostic solutions, Bio-Techne also has a growing portfolio of clinical diagnostic products. The company's Exosome Diagnostics subsidiary is a leader in the development of liquid biopsy tests for cancer diagnosis and monitoring.
Bio-Techne's leadership team is comprised of experienced executives with a track record of success in the life sciences industry. Charles Kummeth, the company's CEO, has been with Bio-Techne since 2013 and has overseen significant growth and expansion during his tenure.
Overall, Bio-Techne is a company with a strong reputation for innovation, customer service, and leadership in the life sciences industry. With a growing portfolio of products and services, the company is well-positioned for continued success in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $1,071,135 | +22.7% | 13,882 | +8.2% | 0.04% | +9.1% |
Q3 2023 | $873,065 | +10.6% | 12,826 | +32.6% | 0.03% | +13.8% |
Q2 2023 | $789,362 | +14.9% | 9,670 | +4.5% | 0.03% | +7.4% |
Q1 2023 | $686,851 | +89684.4% | 9,258 | +0.3% | 0.03% | -15.6% |
Q4 2022 | $765 | -99.9% | 9,232 | +228.0% | 0.03% | -11.1% |
Q3 2022 | $799,000 | +0.4% | 2,815 | +22.7% | 0.04% | +9.1% |
Q2 2022 | $796,000 | -19.8% | 2,295 | +0.0% | 0.03% | -5.7% |
Q1 2022 | $993,000 | +6.3% | 2,294 | +27.1% | 0.04% | +12.9% |
Q4 2021 | $934,000 | +15.7% | 1,805 | +8.4% | 0.03% | +6.9% |
Q3 2021 | $807,000 | -1.6% | 1,665 | -8.6% | 0.03% | -3.3% |
Q2 2021 | $820,000 | -10.4% | 1,821 | -24.0% | 0.03% | -14.3% |
Q1 2021 | $915,000 | -3.1% | 2,396 | -19.4% | 0.04% | -7.9% |
Q4 2020 | $944,000 | +12.0% | 2,973 | -12.6% | 0.04% | -2.6% |
Q3 2020 | $843,000 | -6.2% | 3,403 | 0.0% | 0.04% | -13.3% |
Q2 2020 | $899,000 | +53.7% | 3,403 | +10.4% | 0.04% | +32.4% |
Q1 2020 | $585,000 | +17.2% | 3,083 | +35.6% | 0.03% | +54.5% |
Q4 2019 | $499,000 | +35.6% | 2,273 | +20.7% | 0.02% | +29.4% |
Q3 2019 | $368,000 | +1.9% | 1,883 | +8.7% | 0.02% | 0.0% |
Q2 2019 | $361,000 | +8.7% | 1,733 | +3.6% | 0.02% | +6.2% |
Q1 2019 | $332,000 | +37.2% | 1,673 | 0.0% | 0.02% | +14.3% |
Q4 2018 | $242,000 | -13.6% | 1,673 | +22.1% | 0.01% | 0.0% |
Q3 2018 | $280,000 | – | 1,370 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 46,500 | $16,119,000 | 8.75% |
Montanaro Asset Management Ltd | 93,950 | $32,567,000 | 4.90% |
Jackson Square Partners, LLC | 556,157 | $192,786,000 | 4.50% |
STONE RUN CAPITAL, LLC | 22,405 | $7,767,000 | 3.91% |
Ownership Capital B.V. | 655,654 | $227,276,000 | 3.90% |
Brown Capital Management | 839,587 | $291,034,000 | 3.90% |
Sandhill Capital Partners LLC | 97,382 | $33,757,000 | 3.61% |
DF DENT & CO INC | 684,026 | $237,111,000 | 3.34% |
Westwind Capital | 27,946 | $9,687,000 | 3.17% |
MAIRS & POWER INC | 655,930 | $227,371,000 | 2.72% |